Product How it works Pricing Blog FAQ About Contact
CAMP4 Therapeutics

CAMP4 Therapeutics (NASDAQ: CAMP) net income

CAMP4 Therapeutics reported a net loss of $80.4m for fiscal 2025; in fiscal 2024 it reported a net loss of $51.8m. Earnings per share were −$2.65.

CAMP4 Therapeutics's best year of the last 3 was fiscal 2023. It reported a loss in 3 of those 3 years.

Net income, in millions of US dollars-49.32023-51.82024-80.42025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Net income by fiscal year

Fiscal yearNet incomeChangeNet marginEarnings per share
2025−$80.4m—−2,298.5%−$2.65
2024−$51.8m—−7,943.4%−$11.04
2023−$49.3m—−14,083.1%−$124.80

The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

CAMP4 Therapeutics net income compared with its sector

By net income for its latest fiscal year, CAMP4 Therapeutics ranks 313th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of CAMP4 Therapeutics, −2,298.5%.

RankCompanyNet incomeNet margin
311thX4 Pharmaceuticals−$79.2m−225.6%
312thBeam Therapeutics−$80.0m−57.2%
313thCAMP4 Therapeutics−$80.4m−2,298.5%
314thSTAAR Surgical−$80.4m−33.6%
315thBioage Labs−$80.6m−896.1%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the net income of CAMP4 Therapeutics

How much did CAMP4 Therapeutics earn in fiscal 2025?
CAMP4 Therapeutics reported a net loss of $80.4m for fiscal 2025. In fiscal 2024 it reported a net loss of $51.8m.
What are the earnings per share of CAMP4 Therapeutics?
They were −$2.65 in fiscal 2025, compared with −$11.04 in fiscal 2024.
Where does CAMP4 Therapeutics rank in its sector by net income?
It ranks 313th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
Where do the figures for CAMP4 Therapeutics come from?
From the annual report (Form 10-K) that CAMP4 Therapeutics files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that CAMP4 Therapeutics files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023. More on CAMP4 Therapeutics: the CAMP4 Therapeutics page · annual accounts · revenue · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.